Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Revenue

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,051 Cr₹134,033 Cr₹1,320 Cr₹1,010 Cr₹834 Cr

What is the latest Revenue of SUVEN PHARMACEUTICALS ?

The latest Revenue ratio of SUVEN PHARMACEUTICALS is ₹1,051 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,051 Cr
Mar2024₹134,033 Cr
Mar2023₹1,320 Cr
Mar2022₹1,010 Cr
Mar2021₹834 Cr

How is Revenue of SUVEN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹1,051 Cr
-99.22
Mar2024 ₹134,033 Cr
10,052.30
Mar2023 ₹1,320 Cr
30.75
Mar2022 ₹1,010 Cr
21.10
Mar2021 ₹834 Cr -

Compare Revenue of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹11,812.8 Cr -1.8% -18.9% -74.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-1.8%

-18.9%

-74.9%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses